期刊
CURRENT DIABETES REPORTS
卷 17, 期 11, 页码 -出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-017-0933-9
关键词
Type 1 diabetes; Microbiome; Microbiota; Prebiotics; Probiotics; Diet
资金
- Juvenile Diabetes Research Foundation International [4-1998-274, 4-1999-731, 4-2001-435]
- European Union [BMH4-CT98-3314]
- Novo Nordisk Foundation
- Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]
- Special Research Funds for University Hospitals in Finland
- Sigrid Juselius Foundation
- Finska Lakaresallskapet
- Medicinska understosforeningen Liv och Halsa
Purpose of Review The purpose of this review is to summarize potential modulations of the intestinal microbiome aimed at preventing or delaying progression to overt type 1 diabetes in the light of recently identified perturbations of the gut microbiota associated with the development of type 1 diabetes. Recent Findings Accumulated data suggest that the gut microbiota is involved at two different steps in the evolution of type 1 diabetes. At the first step, the intestinal tract is colonized by a microbial community unable to provide an adequate education of the immune system. As a consequence, the infant acquires susceptibility to immune-mediated diseases, type 1 diabetes included. At the other step, the young child seroconverts to positivity for diabetes-associated autoantibodies. This is preceded or accompanied by a decrease in the diversity of the intestinal microbiota and an increased abundance of Bacteroides species. These changes will affect the disease process promoting progression toward overt type 1 diabetes. Summary By providing specific probiotics, one can affect the colonization of the intestinal tract in the newborn infant or strengthen the immune education in early life. Human milk oligosaccharides function as nutrients for healthy bacteria. Dietary interventions applying modified starches can influence the numbers and activities of both autoreactive and regulatory T cells and provide protection against autoimmune diabetes in non-obese diabetic mice. Modulation of the intestinal microbiome holds the promise of effective protection against human type 1 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据